2022 YEAR IN REVIEW – #SOLUTIONSWATCH

December 21st, 2022 Another year of #SolutionsWatch has come and gone and so it’s time for James to take a moment to take stock of this year’s episodes. What resonated? What didn’t? What can be applied moving forward? What new developments have taken place? Don’t miss this comprehensive year-in-review edition of Solutions Watch.

A Review and Autopsy of Two COVID Immunity Studies

By Martin Kulldorff   November 2, 2021 How effective is immunity after Covid recovery relative to vaccination? An Israeli study by Gazit et al. found that the vaccinated have a 27 times higher risk of symptomatic infection than the Covid recovered. At the same time, the vaccinated were nine times more likely to be hospitalized

Patents Review shows SARS-CoV-2 is no novel Virus

Dr. David Martin -July 9 2021 Dr. David Martin, CEO of M-CAM International (risk management) has reviewed 4,000 Coronavirus patents. He appeared on Sitting #60 of the German Corona Committee on July 9 2021 to share his findings in a 90 minute discussion with lawyers of the Ausschuss and Dr. Wolfgang Wodarg, Germany’s most experienced